Just reading a few old announcement and I was wondering if anyone knows anything about the Pivotal trial that was meant to have commenced back in March 2014? Did this actually occur or is it underway? There is a mention about possibly presenting interim results after data from at least 30 patients is available but I can't see any subsequent announcements relating to this.
Not to be negative, but if the above mentioned trial is not well underway, it would appear that the existing data for Oncosil is extremely limited. All they have is data from a pilot trial many years ago. What happened to that 10$m they raised during the placement a few years back? With limited trial data, it is seemingly more apparent that the application requirements of the CE Mark approval would be difficult to achieve.
Thoughts?
OSL Price at posting:
10.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)